|   In the News

IFM Lands $55.5M to Launch NewCo Quattro and Discovery Incubator


IFM Therapeutics has raised $55.5 million to launch its third drug subsidiary as well as an incubator, both of which are focused on developing new therapies for inflammatory diseases and cancers.

Read more.